Short or Conventional Length Femoral Stem Study (SCoFS)

  • Research type

    Research Study

  • Full title

    Randomised Controlled Trial of Short and Conventional Length Cemented Total Hip Replacement

  • IRAS ID

    336246

  • Contact name

    Antony Palmer

  • Contact email

    Antony.palmer@ouh.nhs.uk

  • Sponsor organisation

    Oxford University Hospitals

  • Duration of Study in the UK

    4 years, 0 months, 1 days

  • Research summary

    This study is a single-centre, participant-blinded, randomised controlled equivalence trial evaluating outcomes of short versus conventional-length cemented stems in hybrid total hip replacement. We aim to recruit 106 adult patients undergoing elective hybrid total hip arthroplasty (THA) at the Nuffield Orthopaedic Centre, Oxford, who meet eligibility criteria and provide informed consent.

    Participants will be randomly allocated in a 1:1 ratio on the day of surgery to receive either (1) a short cemented polished taperslip femoral stem or (2) a standard-length cemented polished taperslip stem, with all other components, surgical technique and perioperative care being standardised and consistent between groups. Both implants are already in routine clinical use within the NHS. The intervention occurs during the patient’s standard THA procedure, after which recovery follows conventional care pathways.

    Total participation duration is three years from surgery. Pre-operative assessments include baseline demographic and clinical data collection, routine pre-operative radiographs and completion of established hip outcome PROMs (Oxford Hip Score, EuroQol EQ-5D, Forgotten Joint Score). Usual postoperative care is followed, including inpatient physiotherapy and a routine postoperative X-ray. In addition to routine care, participants will undergo a DEXA scan within two weeks following surgery to establish baseline bone mineral density surrounding the femoral stem. They will attend the routine 6-week clinical review and receive routine PROMs at six months post-operatively. The final study visit occurs at three years, when participants return for a research pelvic X-ray, repeat DEXA scan and repeat PROMs completion. Intraoperative data including operative time and estimated blood loss will be collected at the time of surgery, and complications, withdrawals or revisions will be monitored throughout the study period.

    The primary objective is to determine whether short stems demonstrate equivalent change in calcar bone mineral density compared to conventional stems at three years following surgery, measured using DEXA scanning. Secondary outcomes include intraoperative factors (blood loss, operative duration), postoperative function via PROMs, radiological assessment of radiolucent lines, and implant survivorship measured through revision for any reason. All data will be analysed on an intention-to-treat basis. The study will improve understanding of the biomechanical bone response to cemented stem length and provide medium-term clinical evidence to guide implant selection.

  • REC name

    East Midlands - Nottingham 1 Research Ethics Committee

  • REC reference

    25/EM/0253

  • Date of REC Opinion

    18 Nov 2025

  • REC opinion

    Favourable Opinion